Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Leo James's Biography

Leo James, , MRC Laboratory of Molecular Biology

Leo received his Ph.D. from Cambridge University in 2000, where he worked on antibody structure and design including the first humanised antibody CAMPATH. He post-doc’d in the labs of Prof. Dan Tawfik and Sir Greg Winter, investigating molecular mechanisms of antibody pathogenicity. In 2007, Leo established an independent group at the Laboratory of Molecular Biology in Cambridge ( His lab studies intracellular host-pathogen interactions, in particular during early post-entry infection, using a broad range of in vitro and in vivo techniques. Leo’s lab discovered the interface on HIV capsid that is used to recruit cofactors for nuclear import and the dynamic pores through which the virus recruits dNTPs for encapsidated DNA synthesis. He also discovered TRIM21, the mammalian cytosolic antibody receptor, and continues to work on the molecular mechanisms that underpin intracellular humoral immunity and its role in antiviral defence.

Leo James Image

Intracellular Antibody Immunity and the Cytosolic Fc Receptor TRIM21

Tuesday, 7 March 2017 at 16:15

Add to Calendar ▼2017-03-07 16:15:002017-03-07 17:15:00Europe/LondonIntracellular Antibody Immunity and the Cytosolic Fc Receptor

In my talk I will summarize key aspects of TRIM21 biology, and recent data showing how dual sensing and effector functions are regulated, how TRIM21 integrates with other innate immune sensors and the neutralization of aggregates involved in neurodegenerative disease.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug